Common name
2-phenylacetamide
IUPAC name
2-phenylacetamide
SMILES
O=C(N)Cc1ccccc1
Common name
2-phenylacetamide
IUPAC name
2-phenylacetamide
SMILES
O=C(N)Cc1ccccc1
INCHI
InChI=1S/C8H9NO/c9-8(10)6-7-4-2-1-3-5-7/h1-5H,6H2,(H2,9,10)
FORMULA
C8H9NO
Common name
2-phenylacetamide
IUPAC name
2-phenylacetamide
Molecular weight
135.163
clogP
1.306
clogS
-1.603
Frequency
0.0058
HBond Acceptor
1
HBond Donor
2
Total PolarSurface Area
43.09
Number of Rings
1
Rotatable Bond
2
| Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
|---|---|---|---|---|
| FDBD00167 | Disopyramide |
|
Anti-Arrhythmia Agents; Voltage-Gated Sodium Channel Blockers; Cardiovascular System; Antiarrhythmics, Class I and Iii; Cardiac Therapy; Antiarrythmics, Class I and Iii; Antiarrhythmics, Class Ia; CYP3A4 Inhibitors; | For the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, ventricular pre-excitation and cardiac dysrhythmias. It is a Class Ia antiarrhythmic drug. |
| FDBD00205 | Piperacillin |
|
Anti-Bacterial Agents; Penicillins; Antibacterials for Systemic Use; Antiinfectives for Systemic Use; Beta-Lactam Antibacterials, Penicillins; Penicillins With Extended Spectrum; | For the treatment of polymicrobial infections. |
| FDBD00220 | Atenolol |
|
Antihypertensive Agents; Adrenergic beta-1 Receptor Antagonists; Sympatholytics; Anti-Arrhythmia Agents; Cardiovascular System; Beta Blocking Agents, Selective; Beta Blocking Agents; Beta Blocking Agents, Selective, and Thiazides; Beta Blocking Agents and Thiazides; | For the management of hypertention and long-term management of patients with angina pectoris. |
| FDBD00369 | Darifenacin |
|
Muscarinic Antagonists; Antispasmodic Agents; Genito Urinary System and Sex Hormones; Drugs for Urinary Frequency and Incontinence; Urological Agents; CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors; | For the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. |
| FDBD00671 | Tropicamide |
|
Muscarinic Antagonists; Mydriatics; Diagnostic Agents; Ophthalmologicals; Sensory Organs; Anticholinergics; Mydriatics and Cycloplegics; | Indicated to induce mydriasis (dilation of the pupil) and cycloplegia (paralysis of the ciliary muscle of the eye) in diagnostic procedures, such as measurement of refractive errors and examination of the fundus of the eye. |
| FDBD00753 | Benzylpenicilloyl Polylysine |
|
Acetamides; | For use as a adjunct in assessing the risk of administering penicillin (benzylpenicillin or penicillin G). |
| FDBD00780 | Ceforanide |
|
Anti-Bacterial Agents; Cephalosporins; Antibacterials for Systemic Use; Antiinfectives for Systemic Use; Second-Generation Cephalosporins; | For the treatment of infections caused by susceptible organisms. |
| FDBD00803 | Mezlocillin |
|
Anti-Bacterial Agents; Penicillins; Antibacterials for Systemic Use; Antiinfectives for Systemic Use; Beta-Lactam Antibacterials, Penicillins; Penicillins With Extended Spectrum; | Used to treat serious gram–negative infections of the lungs, urinary tract, and skin. |
| FDBD00904 | Benzylpenicillin |
|
Anti-Bacterial Agents; Penicillins; Antibiotics; Ophthalmologicals; Sensory Organs; Antibacterials for Systemic Use; Antiinfectives for Systemic Use; Antiinfectives; Antibacterials for Intramammary Use; Beta-Lactam Antibacterials, Penicillins; Beta-Lactam Antibacterials, Penicillins, for Intramammary Use; Beta-Lactamase Sensitive Penicillins; | For use in the treatment of severe infections caused by penicillin G-susceptible microorganisms when rapid and high penicillin levels are required such as in the treatment of septicemia, meningitis, pericarditis, endocarditis and severe pneumonia. |
| FDBD00912 | Azlocillin |
|
Anti-Bacterial Agents; Penicillins; Antibacterials for Systemic Use; Antiinfectives for Systemic Use; Beta-Lactam Antibacterials, Penicillins; Penicillins With Extended Spectrum; | For the treatment of infections caused by . |
17 ,
2
| FRAGNAME | PDBID | SIMILIRITY | XSCORE | SMILE | HAC |
|---|---|---|---|---|---|
| 3ahn_ligand_2_0.mol2 | 3ahn | 1 | -6.99 | c1(ccccc1)CC(=O)N | 10 |
| 1hte_ligand_2_20.mol2 | 1hte | 1 | -6.71 | c1c(cccc1)CC(=O)N | 10 |
| 1htf_ligand_2_56.mol2 | 1htf | 1 | -6.62 | c1ccccc1CC(=O)N | 10 |
| 1htg_ligand_2_54.mol2 | 1htg | 1 | -6.62 | C(=O)(N)Cc1ccccc1 | 10 |
| 4kqq_ligand_2_14.mol2 | 4kqq | 1 | -6.61 | c1(ccccc1)CC(=O)N | 10 |
| 4kqr_ligand_2_14.mol2 | 4kqr | 1 | -6.56 | O=C(N)Cc1ccccc1 | 10 |
| 4kqo_ligand_2_14.mol2 | 4kqo | 1 | -6.54 | c1(ccccc1)CC(=O)N | 10 |
| 4nie_ligand_2_49.mol2 | 4nie | 1 | -6.53 | C(c1ccccc1)C(=O)N | 10 |
188 ,
19
